Do Analysts Agree Friday on Spectrum Pharmaceuticals, Inc. (SPPI) Stock's Target Price?

Friday, October 22, 2021 03:15 PM | InvestorsObserver Analysts

Mentioned in this article

Do Analysts Agree Friday on Spectrum Pharmaceuticals, Inc. (SPPI) Stock's Target Price?

InvestorsObserver is giving Spectrum Pharmaceuticals, Inc. (SPPI) an Analyst Rating Rank of 54, meaning SPPI is ranked higher by analysts than 54% of stocks. The average price target for SPPI is $6.75 and analyst’s rate the stock as a Strong Buy.

Wall Street analysts are rating SPPI a Strong Buy today. Find out what this means to you and get the rest of the rankings on SPPI!

See Full SPPI Report

Why are Analyst Ratings Important?

Analytical research by professionals can be extremely useful when making investment decisions in the stock market. Analysts are able to observe industries in detail and learn how geographical impacts can affect a company's balance sheet. This information allows investors to make decisions ahead of the curve. InvestorsObserver combines the ratings from these analysts and proceeds to percentile rank them. This grants you the ability to compare stocks in a comprehensive fashion as oppossed to a standard buy/hold/sell rating.

What's Happening With Spectrum Pharmaceuticals, Inc. Stock Today?

Spectrum Pharmaceuticals, Inc. (SPPI) stock is up 0.5% while the S&P 500 is lower by -0.14% as of 3:10 PM on Friday, Oct 22. SPPI is higher by $0.01 from the previous closing price of $1.99 on volume of 983,543 shares. Over the past year the S&P 500 is higher by 31.56% while SPPI is lower by -44.60%. SPPI lost -$1.22 per share the over the last 12 months. Click Here to get the full Stock Report for Spectrum Pharmaceuticals, Inc. stock.